# AstraZeneca drug combination helps lung cancer patients live longer in late-stage study

https://mins.news/en/item/50207

- Reuters, 2026-09-08 18:30 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/astrazenecas-cancer-drug-combo-hits-main-survival-goal-late-stage-trial-2026-09-08/?link_source=ta_bluesky_link&taid=6aa0544251db2900015ec047

> AstraZeneca said its cancer drug Imfinzi, combined with Amgen’s targeted immunotherapy Imdelltra, significantly improved overall survival for patients with extensive-stage small-cell lung cancer in a late-stage trial.